Dapsone and Shock - a phase IV clinical study of FDA data
Summary:
Shock is reported as a side effect among people who take Dapsone (dapsone), especially for people who are male, 50-59 old, also take Ciclosporin, and have Acute myeloid leukaemia.
The phase IV clinical study analyzes which people have Shock when taking Dapsone. It is created by eHealthMe based on reports of 11,499 people who have side effects when taking Dapsone from the FDA, and is updated regularly.
What is Dapsone?
Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.
What is Shock?
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,213 drugs and 1,755 conditions by eHealthMe. Check the latest studies of Shock.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11,499 people reported to have side effects when taking Dapsone.
Among them, 33 people (0.29%) have Shock.

Among these 33 people:
What is the gender of people who have Shock when taking Dapsone? *
- female: 18.75 %
- male: 81.25 %
What is the age of people who have Shock when taking Dapsone? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 6.25 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 9.38 %
- 50-59: 53.12 %
- 60+: 31.25 %
What are other drugs people take besides Dapsone? *
- Ciclosporin: 12 people, 36.36%
- Prednisone: 8 people, 24.24%
- Acetaminophen: 7 people, 21.21%
- Alprazolam: 7 people, 21.21%
- Methylprednisolone: 7 people, 21.21%
- Mycophenolate Mofetil: 7 people, 21.21%
- Omeprazole: 7 people, 21.21%
- Ezetimibe: 6 people, 18.18%
- Gabapentin: 6 people, 18.18%
- Lasix: 6 people, 18.18%
What are other side effects people have besides Shock? *
- Hypotension (abnormally low blood pressure): 21 people, 63.64%
- Fever: 19 people, 57.58%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 19 people, 57.58%
- Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 13 people, 39.39%
- Pneumonia Cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses): 13 people, 39.39%
- Leukoencephalopathy (disease of the white matter in the brain): 12 people, 36.36%
- Diffuse Alveolar Damage (common manifestation of drug-induced lung injury): 12 people, 36.36%
- Infection Reactivation: 11 people, 33.33%
- Encephalitis (inflammation of the brain): 11 people, 33.33%
- Mobility Decreased (ability to move is reduced): 11 people, 33.33%
What are the existing conditions these people have? *
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 11 people, 33.33%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 11 people, 33.33%
- Graft Versus Host Disease In Lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung): 4 people, 12.12%
- Chronic Allograft Nephropathy (failure of kidney transplant): 2 people, 6.06%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.03%
- Arthritis Reactive (autoimmune condition that develops in response to an infection in another part of the body): 1 person, 3.03%
- Blood Testosterone Decreased: 1 person, 3.03%
- Depression: 1 person, 3.03%
- Dizziness: 1 person, 3.03%
- Renal Cell Carcinoma (a kidney cancer): 1 person, 3.03%
* Approximation only. Some reports may have incomplete information.
Do you take Dapsone and have Shock?
- Check whether Shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Dapsone:
- Dapsone (11,732 reports)
Shock treatments and more:
- Shock (28,534 reports)
How severe was Shock and when was it recovered:
Expand to all the drugs that have ingredients of dapsone:
- Shock and drugs with ingredients of dapsone (13 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dapsone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Shock:
- Shock (1,213 drugs)
Browse all the conditions that are associated with Shock:
- Shock (1,755 conditions)
Related publications that referenced our studies
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on dapsone (the active ingredients of Dapsone) and Dapsone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Olmesartan Medoxomil cause Enlarged Prostate? - now
- Sulfasalazine and Cellulitis for Men aged 50-59 - 11 seconds ago
- Sulfasalazine and Skin Infection - Bacterial for Men aged 50-59 - 12 seconds ago
- Leg Pain in Omega-3, how severe and when it was recovered? - 14 seconds ago
- Could Flecainide Acetate cause Rectal Polyp? - 18 seconds ago
- Could Symbyax cause Heavy Or Prolong Menstrual Bleeding? - 21 seconds ago
- Could Cytoxan cause Diverticulitis Aggravated? - 24 seconds ago
- Could Lithium Carbonate cause Psoriatic Arthropathy Aggravated? - 34 seconds ago
- Could Cefepime Hydrochloride cause Atrial Fibrillation Aggravated? - 35 seconds ago
- Azithromycin and Methotrexate drug interactions for girls aged 10-19 - 36 seconds ago